Author Question: A patient begins taking a new drug that causes pupil dilation, vasoconstriction, decreased ... (Read 85 times)

CORALGRILL2014

  • Hero Member
  • *****
  • Posts: 525
A patient begins taking a new drug that causes pupil dilation, vasoconstriction, decreased gas-trointestinal motility, and goose bumps. Which of the following receptors are activated?
 
  a. 1
  b. 2
  c. 1
  d. 2

Question 2

Which of the following is a neuroglial cell? (select all that apply)
 
  a. Astrocyte
  b. Oligodendrocyte
  c. Neuron
  d. Ependymal cell
  e. Melanocyte



marict

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: A
1 stimulation leads to pupil dilation. 2 stimulation leads to inhibition of intestinal secretions. 1 stimulation leads to miosis or pupillary constriction. 2 stimulation leads to pupillary constriction.

Answer to Question 2

ANS: A, B, D
Neuroglial cells include astrocytes, oligodendrocytes, and ependymal cells. Neurons and mela-nocytes are not neuroglial cells.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library